2016 Dec 12
The Cancer Lottery
Harold Varmus, M.D., discusses some of the "lost opportunities" in cancer genomics. Read more
2016 Dec 10
Greater collaboration may improve outcomes in pancreatic cancer
Two recent features highlighted the efforts of Allyson Ocean, M.D., to involve patients in their treatments for pancreatic cancer. Read more
2016 Dec 09
Vahdat presents promising new treatment for triple negative breast cancer
Linda Vahdat, M.D., MBA, presented promising results of the use of IMMU-132 to treat triple-negative breast cancer. Read more
2016 Dec 09
The P.A.Th. to better models
Researchers at Weill Cornell Medicine and the Cornell University College of Veterinary Medicine have undertaken an ambitious $5 million project to create new model systems that accurately reflect the biology, genetics and tumor-host interactions of difficult-to-treat blood cancers. Read more
2016 Dec 09
Hematologists present research at 2016 ASH conference
Thousands of hematologists gathered in San Diego on Dec. 3 for the 58th Annual Meeting of the American Society of Hematology (ASH), and Weill Cornell Medicine/NewYork-Presbyterian was well represented. Read more
2016 Dec 07
Infections after prostate biopsy continue to rise
Infectious complication rates following prostate biopsies continue to increase, despite decreased use of the procedures, according to Jim Hu, M.D. Read more
2016 Nov 28
Treating advanced gastroesophageal cancers
Manish Shah, M.D., discusses aspects of treating gastroesophagael cancers, including molecular testing and multidisciplinary management. Read more
2016 Nov 21
Cancer cells 'talk' to their environment, and it talks back
A multidisciplinary team led by Ithaca member Mingming Wu has devised a method for measuring the force a breast cancer cell exerts on its fibrous surroundings. Read more
2016 Nov 19
Therapeutic Metabolic Targets in Brain Cancer
Howard Fine, M.D., discusses the importance of novel metabolic targets, such as IDH mutations, in the field of neuro-oncology. Read more
2016 Nov 18
Tracing Cancer’s Roots
Marcin Imielinski, M.D., Ph.D., and Dan Avi Landau, M.D., Ph.D, are using genomics to better understand—and combat—tumors. Read more
2016 Nov 17
Genetic screening for cancer prevention: Many choices
Steven Lipkin, M.D., Ph.D., reviews options for genetic screening in cancer prevention and its technical, legal and social considerations. Read more
2016 Nov 16
Volunteer makeup artists pamper patients during cancer treatment
Lipstick Angels, a non-profit that brings volunteer makeup artists into hospitals to treat them with facials, makeovers and massage treatments has started a program at NewYork-Presbyterian. Read more
2016 Nov 14
Remission without admission
An innovative clinical trial at Weill Cornell Medicine has helped Ralph Hills recover from an aggressive leukemia - without ever being admitted to the hospital. Read more
2016 Nov 11
Anticipated METRIC results could lead to first targeted agent approved in TNBC
Findings from a highly anticipated, randomized, phase II trial could possibly pave the path for the FDA approval of the first targeted therapy for patients with triple-negative breast cancer (TNBC), explains Linda T. Vahdat, M.D. Read more
2016 Nov 10
Innovative Online Community Offers Guidance to Patients With Pancreatic Cancer and Their Families
Allyson Ocean, M.D., discusses the impetus and mission of the online community she formed with pancreatic cancer patient Anne Glauber. Read more
2016 Nov 10
In the OR, it's as if she's my own child
Surgery by Drs Theodore Schwartz and Jeffrey Greenfield saved a toddler's vision - and life. Read more
2016 Nov 09
Daedalus fund supports innovative cancer research
Two cancer center members were among seven selected for the third round of the Daedalus Fund for Innovation awards. Read more
2016 Nov 09
Trumping Science?
Harold Varmus, M.D., suggests that President-elect Trump and his advisors receive a science “tutorial” before taking office. Read more
2016 Nov 08
Pancreas and colon tumors reprogram the liver, causing wasting and short-circuiting body's immune response
A team led by Doug Fearon, M.D., has traced cachexia to a molecular reprogramming of the liver induced by tumors, which also releases stress hormones that can prevent the immune system from responding. Read more
2016 Nov 08
Doctors should consider physiology of obese patients when designing cancer treatment
The metabolic state of patients influences their cancer risk, progression and response to treatment, warns researchers in the lab of Meyer director Lewis Cantley. Read more
